In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

Spending on drugs purchased at discounted 340B prices across all participating facilities went up 19% annually between 2010 and 2021, according to a June 17 report from the Congressional Budget Office ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

Community-based practices are under increasing pressure to sell or close due to the unintended consequences of a rapidly ...

As many have now heard, on Thursday, August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) released the prices for the first 10 prescription drugs selected for negotiation with ...

On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...

The Centers for Medicare and Medicaid Services’ Medicare GLP-1 Bridge program will decrease certain GLP-1 costs, which local ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald Trump answered that call. His executive order aims to bring down drug prices ...

Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. Most state Medicaid programs don’t cover the new class of weight loss drugs for obesity, but that ...